An analytical comparison of the three most commonly used prostate-specific antigen assays: Tandem-R, Tandem-E, and IMx

By Oesterling J.E.   Moyad M.A.   Wright G.L.   Beck G.R.  

Urology, Vol. 46, Iss. 4, 1995-10 ,pp. : 524-532

Elsevier

Access to resources Recommend Favorite

Determination of the ''reflex range'' and appropriate cutpoints for percent free prostate-specific antigen in 413 men referred for prostatic evaluation using the AxSYM system

By Vashi A.R.   Wojno K.J.   Henricks W.   England B.A.   Vessella R.L.   Lange P.H.   Wright G.L.   Schellhammer P.F.   Weigand R.A.   Olson R.M.   Dowell B.L.   Borden K.K.   Oesterling J.E.  

Urology, Vol. 49, Iss. 1, 1997-01 ,pp. : 19-27

Elsevier

Access to resources Recommend Favorite

Probability of prostate cancer detection based on results of a multicenter study using the AxSYM free PSA and total PSA assays

By Vessella R.L.   Lange P.H.   Partin A.W.   Chan D.W.   Sokoll L.J.   Sasse E.A.   Crawford E.D.  

Urology, Vol. 55, Iss. 6, 2000-06 ,pp. : 909-914

Elsevier

Access to resources Recommend Favorite

Relationship between serum prostate-specific antigen and calculated epithelial volume

By Fukatsu A.   Ono Y.   Ito M.   Yoshino Y.   Hattori R.   Gotoh M.   Ohshima S.  

Urology, Vol. 61, Iss. 2, 2003-02 ,pp. : 370-374

Elsevier

Access to resources Recommend Favorite

Comparison of two investigative assays for the complexed prostate-specific antigen in total prostate-specific antigen between 4.1 and 10.0 ng/mL

By Okegawa T.   Noda H.   Nutahara K.   Higashihara E.  

Urology, Vol. 55, Iss. 5, 2000-05 ,pp. : 700-704

Elsevier

Access to resources Recommend Favorite